The corticotropin-releasing factor (CRF) system mediates stress responses. Extrahypothalamic CRF 1 receptor activation has anxiogenic-like properties, but anxiety-related functions of CRF 2 receptors remain unclear. The present study determined the effects of intracerebroventricular administration of a CRF 2 agonist, urocortin 3, on behavior of male Wistar rats in the shock-probe, social interaction, and defensive withdrawal tests of anxiety-like behavior. Equimolar doses of stressin 1 -A, a novel CRF 1 agonist, were administered to separate rats. The effects of pyrazolo[1,5-a]-1,3,5-triazin-4-amine,8-[4-(bromo)-2-chlorophenyl]-N,N-bis(2-methoxyethyl)-2,7-dimethyl-(9Cl) (MJL-1-109-2), a CRF 1 antagonist, on behavior in the shockprobe test also were studied. Stressin 1 -A increased anxiety-like behavior in the social interaction and shock-probe tests. Stressin 1 -A elicited behavioral activation and defensive burying at lower doses (0.04 nmol), but it increased freezing, grooming, and mounting at 25-fold higher (1-nmol) doses. Conversely, systemic administration of MJL-1-109-2 (10 mg/kg) had anxiolytic-like effects in the shock-probe test. Unlike stressin 1 -A or MJL-1-109-2, i.c.v. urocortin 3 infusion did not alter anxiety-like behavior in the shock-probe test across a range of doses that reduced locomotion and rearing and increased grooming. Urocortin 3 also did not decrease social interaction, but it decreased anxiety-like behavior in the defensive withdrawal test at a 2-nmol dose. Thus, i.c.v. administration of CRF 1 and CRF 2 agonists produced differential, but not opposite, effects on anxiety-like behavior. Urocortin 3 (i.c.v.) did not consistently decrease or increase anxiety-like behavior, the latter unlike effects seen previously after local microinjection of CRF 2 agonists into the septum or raphe. With increasing CRF 1 activation, however, the behavioral expression of anxiety qualitatively changes from "coping" to "noncoping" and offensive, agonistic behaviors.The corticotropin-releasing factor (CRF) system is a peptide family [CRF and urocortins (Ucns)] and their G proteincoupled receptors (CRF 1 and CRF 2 ) implicated in stress responses. Since CRF was isolated, three mammalian prohormones that contain CRF-like sequences were identified (Ucn 1, 2, and 3). CRF is a potent CRF 1 agonist, but it is a lower affinity CRF 2 agonist. Ucn 1 is a potent agonist for both subtypes. In contrast, Ucn 2 and Ucn 3 have much greater potency at membrane CRF 2 than CRF 1 receptors. CRF and Ucn 1 also bind the corticotropin-releasing factor binding protein (CRF-BP) and soluble CRF 2(a) receptor; Ucn 2 and Ucn 3 bind these proteins with less (Ucn 2) or negligible (Ucn 3) affinity. These pharmacological and related primary structure differences led to Ucn 2 and Ucn 3 being